BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3508720)

  • 1. Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro.
    Chambers TJ; Fuller K; Darby JA; Pringle JA; Horton MA
    Bone Miner; 1986 Apr; 1(2):127-35. PubMed ID: 3508720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells.
    Chambers TJ; Fuller K; McSheehy PM; Pringle JA
    J Pathol; 1985 Apr; 145(4):297-305. PubMed ID: 2987469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens.
    Horton MA; Lewis D; McNulty K; Pringle JA; Chambers TJ
    Cancer Res; 1985 Nov; 45(11 Pt 2):5663-9. PubMed ID: 4053038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of bone resorption by a monoclonal antibody that reacts with a 150 kD membrane protein in chicken osteoclasts.
    Hentunen TA; Lakkakorpi PT; Rautiala T; Väänänen HK
    J Bone Miner Res; 1991 Oct; 6(10):1091-7. PubMed ID: 1724590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
    McSheehy PM; Chambers TJ
    J Clin Invest; 1987 Aug; 80(2):425-9. PubMed ID: 3611354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclasts are capable of particle phagocytosis and bone resorption.
    Wang W; Ferguson DJ; Quinn JM; Simpson AH; Athanasou NA
    J Pathol; 1997 May; 182(1):92-8. PubMed ID: 9227347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
    Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
    J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myosin II antibodies inhibit the resorption activity of isolated rat osteoclasts.
    Sato M; Grasser W
    Cell Motil Cytoskeleton; 1990; 17(3):250-63. PubMed ID: 2268876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
    Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
    J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reappraisal of the effect of extracellular calcium on osteoclastic bone resorption.
    Hall TJ
    Biochem Biophys Res Commun; 1994 Jul; 202(1):456-62. PubMed ID: 8037747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cell-surface Ag expressed on rat osteoclasts regulating the function of the calcitonin receptor.
    Kukita T; Kukita A; Nagata K; Maeda H; Kurisu K; Watanabe T; Iijima T
    J Immunol; 1994 Dec; 153(11):5265-73. PubMed ID: 7963580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.
    O'Keefe RJ; Teot LA; Singh D; Puzas JE; Rosier RN; Hicks DG
    Lab Invest; 1997 Apr; 76(4):457-65. PubMed ID: 9111508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
    Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
    Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone.
    Reddy SV; Takahashi S; Dallas M; Williams RE; Neckers L; Roodman GD
    J Bone Miner Res; 1994 May; 9(5):753-7. PubMed ID: 8053406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
    Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
    J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
    Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
    J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclasts are present in the giant cell variant of malignant fibrous histiocytoma.
    Flanagan AM; Chambers TJ
    J Pathol; 1989 Sep; 159(1):53-7. PubMed ID: 2553905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.
    Thomson BM; Mundy GR; Chambers TJ
    J Immunol; 1987 Feb; 138(3):775-9. PubMed ID: 3805716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types.
    Horton MA; Rimmer EF; Lewis D; Pringle JA; Fuller K; Chambers TJ
    J Pathol; 1984 Dec; 144(4):281-94. PubMed ID: 6520652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.